Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIxico Share News (IXI)

Share Price Information for Ixico (IXI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 8.125
Bid: 8.00
Ask: 8.25
Change: 0.00 (0.00%)
Spread: 0.25 (3.125%)
Open: 8.125
High: 8.125
Low: 8.125
Prev. Close: 8.125
IXI Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

IN BRIEF: Ixico interim profit falls; warns on cancelled client trials

Tue, 24th May 2022 12:24

Ixico PLC - London-based medical imaging company - Posts lower interim profit for the half year ended March 31. Pretax profit falls to GBP201,000 from GBP635,000 a year ago due to the impact of cancelled client trials. Revenue drops to GBP3.9 million from GBP4.9 million.

For the rest of its financial year, company expects to "materially exceed existing market profit expectations," Ixico says. However, more impact from cancelled client trials will be felt later, firm adds, anticipating weaker revenues in the next year.

"The financial results for the half year are in line with expectations and we anticipate stronger second half trading. I am also encouraged in our progress in commercialising cutting edge analytics tools to provide clinically valuable insights to our global biopharmaceutical clients," comments Chief Executive Officer Giulio Cerroni.

Current stock price: 36.85 pence, down 11% on Tuesday

12-month change: down 56%

By Tom Budszus; tombudszus@alliancenews.com

Copyright 2022 Alliance News Limited. All Rights Reserved.

More News
21 Apr 2022 22:06

TRADING UPDATES: Warehouse REIT buys Bradwell Abbey; Ixico wins deal

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more
21 Apr 2022 13:50

Ixico selected for Huntington's disease detection study

(Sharecast News) - Artificial intelligence (AI) neuroimaging company Ixico announced on Thursday that it has been selected by a new client to support a global prospective observational study, assessing participants for the early detection of Huntington's disease (HD).

Read more
8 Mar 2022 15:31

Ixico wins £0.8m contract with existing US client

(Sharecast News) - Medical analysis company Ixico has been selected by an existing United States biotechnology client, it announced on Tuesday, to provide PET and MRI neuroimaging services for an open-label phase 1 and 2 dose-finding study.

Read more
8 Mar 2022 12:33

TRADING UPDATES: Tasty sales rise; Synectics wins National Grid deal

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

Read more
14 Feb 2022 11:39

Ixico shares rise with launch of new brain segmentation platform

(Alliance News) - Shares in Ixico PLC on Monday rose after the company announced the launch of its new brain segmentation platform IXIQ Ai.

Read more
8 Feb 2022 15:17

Ixico wins contract from new European biopharmaceutical client

(Sharecast News) - Medical imaging analytics company Ixico has been selected to provide PET and MRI imaging services to an unnamed "leading European biopharmaceutical company" specialising in neurodegenerative conditions, it announced on Tuesday.

Read more
8 Feb 2022 11:46

AIM WINNERS & LOSERS: Joules up on upbeat outlook; Numis quarter slow

AIM WINNERS & LOSERS: Joules up on upbeat outlook; Numis quarter slow

Read more
8 Feb 2022 10:06

Ixico wins GBP1 million contract to provide medical imaging services

Ixico wins GBP1 million contract to provide medical imaging services

Read more
26 Jan 2022 16:02

Ixico extends commitment to Dementias Platform UK

(Sharecast News) - Data analytics company Ixico has extended its commitment to Dementias Platform UK (DPUK), it announced on Wednesday, as it entered its second phase.

Read more
20 Jan 2022 14:35

IN BRIEF: IXICO will see 2022 revenue drop after contract canceled

IN BRIEF: IXICO will see 2022 revenue drop after contract canceled

Read more
20 Jan 2022 10:58

AIM WINNERS & LOSERS: Parity and Brave Bison expect to beat forecasts

AIM WINNERS & LOSERS: Parity and Brave Bison expect to beat forecasts

Read more
13 Jan 2022 14:52

UK shareholder meetings calendar - next 7 days

UK shareholder meetings calendar - next 7 days

Read more
7 Dec 2021 15:41

Ixico sees "significant growth" despite notable headwinds; shares up

Ixico sees "significant growth" despite notable headwinds; shares up

Read more
30 Nov 2021 16:26

UK earnings, trading statements calendar - next 7 days

UK earnings, trading statements calendar - next 7 days

Read more
1 Nov 2021 15:43

Ixico tapped for another phase-3 clinical trial

(Sharecast News) - Artificial intelligence (AI) data analytics company Ixico has been selected by its largest pharmaceutical client to provide neuroimaging services for a new phase 3 clinical trial focussed on a demyelinating disorder, it announced on Monday.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.